UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061651
Receipt number R000069047
Scientific Title Effects of Morning Cheese Intake and Light Exposure on Sleep and Activity Rhythms, Health, and Developmental Outcomes in Preschool Children: A Chrononutritional Intervention Study
Date of disclosure of the study information 2026/05/22
Last modified on 2026/05/22 02:33:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Morning Cheese Intake and Morning Light Exposure on Sleep and Daily Rhythms in Preschool Children

Acronym

CHIME-Kids Study: Morning Cheese Intake and Light Exposure for Kids

Scientific Title

Effects of Morning Cheese Intake and Light Exposure on Sleep and Activity Rhythms, Health, and Developmental Outcomes in Preschool Children: A Chrononutritional Intervention Study

Scientific Title:Acronym

CHIME-Kids Trial: CHeese Intake and Morning light Exposure in Kids

Region

Japan


Condition

Condition

Healthy preschool children

Classification by specialty

Not applicable Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of a combined lifestyle intervention consisting of morning cheese intake and extended morning outdoor activity on nocturnal sleep duration at week 4 and related sleep wake rhythm outcomes in preschool children using a cluster randomized controlled trial at the kindergarten nursery school level

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Nocturnal sleep duration at week 4 assessed by actigraphy MTN-221 using the mean of three consecutive weekdays excluding days adjacent to weekends

Key secondary outcomes

1 Nocturnal sleep duration at week 5 assessed by actigraphy
2 Light exposure metrics assessed by light sensor including morning and afternoon illuminance and time above 1000 lx
3 Urinary aMT6s and creatinine adjusted aMT6s Cr
4 Parent reported outcomes including PedsQL SDQ and parenting stress questionnaires
5 Sleep architecture indices (sleep efficiency, sleep onset latency, number and duration of nocturnal awakenings) measured by actigraphy MTN-221
6 Sleep rhythm indices (mean weekday bedtime and wake time, day-to-day variability of bedtime)
7 Total 24-hour sleep duration including daytime naps measured by actigraphy
8 Physical activity (energy expenditure adjusted by basal metabolic rate) measured by actigraphy
9 Media device exposure time assessed by time-use record


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food Behavior,custom

Interventions/Control_1

Intervention group: 4 weeks. At home, participants consume 1 piece of processed cheese (approx 17 g) once daily at breakfast (within 2 hours after waking). In addition, the nursery/kindergarten extends outdoor activity time in the morning (9:00-12:00) by 30 minutes as part of routine childcare; when outdoor activity is not feasible, activities are conducted indoors in a bright environment.

Interventions/Control_2

Control group: 4 weeks. Usual lifestyle without additional food intervention or extended morning outdoor activity (no treatment control).

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

3 years-old <=

Age-upper limit

6 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Children aged 3-6 years at study start

2. Enrolled in a nursery school, kindergarten, or certified child center in Fuchu Town, Aki-gun, Hiroshima, and attending at least 4 days per week

3. Written informed consent obtained from a parent or legal guardian

4. No food allergy to dairy products (milk, cheese, yogurt, etc)

5. Expected to continue attending the same institution during the study period

Key exclusion criteria

1. Diagnosed sleep disorder currently under treatment

2. Severe chronic disease requiring dietary restriction

3. Diagnosed lactose intolerance or history of gastrointestinal symptoms after dairy intake

4. Marked difficulty in wearing the actigraph or completing study procedures (including parent judgement)

5. Planned continuous absence from the institution for 1 week or longer during the study period

6. Other reasons judged inappropriate by the investigators

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Norihisa
Middle name
Last name Tamura

Organization

Hiroshima University

Division name

Graduate School of Humanities and Social Sciences

Zip code

739-8524

Address

1-1-1 Kagamiyama, Higashi-Hiroshima city, Hiroshima, Japan

TEL

0824246803

Email

tamura65@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Norihisa
Middle name
Last name Tamura

Organization

Hiroshima University

Division name

Graduate School of Humanities and Social Sciences

Zip code

739-8524

Address

1-1-1 Kagamiyama, Higashi-Hiroshima city, Hiroshima, Japan

TEL

0824246803

Homepage URL


Email

tamura65@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University

Institute

Department

Personal name

Norihisa Tamura


Funding Source

Organization

Other

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Megmilk Snow Brand Co., Ltd

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee for Clinical Research of Hiroshima University

Address

Kasumi 1-2-3 Minami-Ku, Hiroshima

Tel

082-257-1947

Email

iryo-sinsa@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 05 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 04 Month 15 Day

Date of IRB

2026 Year 05 Month 18 Day

Anticipated trial start date

2026 Year 08 Month 01 Day

Last follow-up date

2026 Year 12 Month 15 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 05 Month 22 Day

Last modified on

2026 Year 05 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069047